December 2023
1. MARGOT N, Pennetzdorfer N, Naik V, Rhee M, et al
   Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA.
   Antivir Ther. 2023;28:13596535231220754.
   

   >> Share

   
   October 2023
2. BASSEL M, Romanus D, Bo T, Sundberg AK, et al
   Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.
   Antivir Ther. 2023;28:13596535231195431.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share